Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls
Recruiting
Phase 2
Interventional Study
Arginine Vasopressin Deficiency
Diabetes Insipidus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 42 (estimated)
- Sponsor
- University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to investigate the potential beneficial effects of intranasal oxytocin compared to placebo on emotion recognition and acute psychosocial stress in patients with arginine vasopressin deficiency compared to matched healthy controls.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria healthy controls
1. Adult healthy volunteers
2. Matched for age, sex, BMI, and oestrogen replacement/menopause/hormonal contraceptives to patients.
3. No medication, except hormonal contraception
Inclusion criteria
1. Adult patients with a confirmed diagnosis of AVP deficiency …
Contacts